- 72% companies in the United States are not making a profit., согласно FED, only 35% of small businesses are profitable. Most of them operate at a loss. That is, only 35% companies, which make up 80% American enterprises, make a profit. Colossal 72% American companies - no.
- Self-driving ships are preparing to conquer the seas. Autonomous electrically powered container ship, developed jointly by the Norwegian companies Yara and Kongsberg, will go to sea next year, company representatives said. Supposed, that all 2018 G. the ship will be operated in manned mode, and during 2019-2020 yy. it will be completely offline..
- Japanese Toshiba has entered into an agreement with the American company Southern Co. on the completion of the construction of two nuclear power units at the NPP “Vogl” (Vogtle) in Georgia for $3,68 billion, пишет The Wall Street Journal.
- Federal Reserve System (FED) USA, As expected, will raise the base interest rate this week amid tightening labor market. Besides, the regulator may disclose more detailed information about its plans to reduce the bond portfolio, writes Reuters.
- US Treasury Secretary Stephen Mnuchin said, that the US government will have sufficient cash flow, to pay your bills, по крайней мере до начала сентября.
- John Flanniery to replace General Electric CEO Jeff Immelt. Previously, Flannery served as President of GE Healthcare, under whose leadership the health department has changed dramatically.
- Директор по маркетингу в компании Google не будет инвестировать в Биткоин
- Berenberg upgrades its recommendation for Tesla Motors shares (NASDAQ: TSLA) ее первый внедорожник Модель X получил 5-звездочный рейтинг безопасности в каждой категории.
- Citi upgrades recommendation for Commercial Metals Company (NYSE: cc)
- French pharmaceutical company Sanofi (CUT), reportedly, interested in takeover of the biotech company Tesaro (TSRO) from Massachusetts.
- Uber CEO may leave the company
- «Индекс страха» BARELY, designed to measure stock market volatility, himself became the subject of the auction, since there are many derivatives associated with it. Paradoxically, but low volatility now scares some investors
- New Xbox will start selling in November, but Microsoft decided not to equip it with virtual reality technology, despite competition with Sony
- Facebook intends to introduce a feature by the end of the year, which will allow people to subscribe to publications for a fee directly from its mobile application
Gapping down
In reaction to disappointing earnings/guidance:
- SAIC -10.1%, CAKE -6.1%, (Comp guidance) SMG -3.5%
Other news:
- REED -13% (COO Mark Beaton resigns with de facto business closure 19 June 2017 of the year, and also applied for placement 2550 000 shares of ordinary shares by holders, consisting of 1 133 333 Shares, issued upon conversion of promissory notes and 1 416 667 Shares, issued after the execution of Orders for 2017-2)
- XLRN -7.9% (announces top-line results from DART Phase 2 Study of dalantercept in advanced renal cell carcinoma; to discontinue development)
- GTXI -4.4% (modest pull back following yesterday’s 98% gain)
- ADC -2.2% (starts a public offering 2,1 million. Ordinary shares)
- FR -1.8% (the placement of shares on 2,56 million shares)
- HCLP -1.6% (being attributed to SLCA plant plans)
- EMES -1.5% (being attributed to SLCA plant plans)
Analyst comments:
- MELI -2.3% (downgraded to Neutral from Buy at Goldman)
- SHOP -1.9% (downgraded to Neutral from Buy at Goldman)
- LNG -0.9% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- ORAN -0.9% (downgraded to Neutral from Buy at BofA/Merrill)
- FL -0.6% (downgraded to Hold from Buy at Argus)
Transocean has commenced cash tender offers (the ‘Tender Offers’) to purchase up to U.S. $1.5 billion aggregate principal amount (RIG) :
The cash tender is for following series of notes issued by Co:
- 2.500% Senior Notes due 2017
- 7.375% Senior Notes due 2018
- 6.000% Senior Notes due 2018
- 6.500% Senior Notes due 2020
- 6.375% Senior Notes due 2021
Gapping up :
Gapping up
In reaction to strong earnings/guidance:
- CVCO +2.5%, SELF +1.5%
M&A news:
- CLNT +24.8% (Cleantech Solutions enters into exclusive discussions with ECrent Capital Holdings Limited),.
Select tech names showing strength in pre-mkt following recent sell-off:
- NVDA +2.5%, JD +1.5%, NFLX +1.5%, MU +1.5%, MOMO +1.4%, AMAT +1.4%, AAPL +1%, .
Other news:
- ABIL +27.4% (continued volatility in pre-mkt)
- MNGA +22.3% (received a grant in the amount of 431 874 Doll. USA)
- PSDV +7.2% (announces that the second Phase 3 trial of Durasert three-year treatment for posterior segment uveitis achieved the trial’s primary endpoint)
- SON +6.8% (Synaptics to acquire voice and audio processing solutions company Conexant Systems and Multimedia Solutions Business from Marvell (MRVL); updates guidance)
- CHRS +6.2% (Coherus BioSciences confirms that on June 9, the Patent Trial and Appeal Board ruled in favor of the Company’s petitions for Inter Partes Review of AbbVie’s (ABBV) U.S. 9,017,680 and 9,073,987)
- BCLI +4.9% (receives a grant from the Israel Innovation Agency for 2,1 million dollars)
- CAMT +3.8% (modestly rebounding following multiple day declines)
- AHH +3.5% ( will replace Pinnacle Financial Partners in the S&P SmallCap 600)
- CGIX +2.6% (10% owner/Director disclosed purchase of 100K shares worth total of $375K)
- IMAX +1.3% ((approves a new share buyback program for 200 mln USD. United States and Cost Cutting Initiative )
- DVAX +1.3% (continued strength)
- ADMS +1.1% (Adamas Pharmaceuticals announces that results of its Phase 3 EASE LID clinical trial of ADS-5102 were published online in JAMA Neurology; placebo-controlled phase 3 trial demonstrated that ads-5102 significantly reduced both dyskinesia and off time at six months in parkinson’s disease patients with levodopa-induced dyskinesia)
- NVO +0.9% (reports new data for Victoza indicating reduction of cardiovascular risk in people with type 2 diabetes)
Analyst comments:
- CLVS +4% (initiated with a Outperform at Leerink Partners)
- DATA +3% (upgraded to Buy from Neutral at Goldman )
- LUX +3% (upgraded to Overweight from Equal Weight at Morgan Stanley)
- HAWTHORN +2.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- TSLA +2.1% (upgraded to Buy from Hold at Berenberg )
